search

Active clinical trials for "Heart Diseases"

Results 1521-1530 of 3529

Cardiovascular Risk Factor Management in HIV Infection

Coronary Heart DiseaseDyslipidemia3 more

There is growing evidence that antiretroviral therapy (ART) increases the risk of coronary heart disease (CHD) through metabolic side effects, such as dyslipidemia, insulin resistance, and type II diabetes. Prevalence of risk factors for CHD in HIV-infected individuals receiving ART in the Swiss HIV Cohort Study (SHCS) is high. This cluster randomised controlled trial is nested into the SHCS and will investigate whether physicians randomised to the routine provision of risk profiles from their patients receiving ART will improve the management of risk factors in HIV-infected patients compared to control physicians not routinely receiving such information. Risk profiles will be generated by the SHCS data center and provided to clinicians in all study centers.

Completed11 enrollment criteria

Preschool Based Obesity Prevention Effectiveness Trial

Cardiovascular DiseasesHeart Diseases1 more

The purpose of this study is to compare changes in body mass index (BMI) among 3- to 5-year-old minority children randomized to a weight control intervention (WCI) or a general health control intervention.

Completed5 enrollment criteria

Reducing Total Cardiovascular Risk in an Urban Community

Cardiovascular DiseasesHeart Diseases5 more

PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.

Completed8 enrollment criteria

Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?

Lung CancerHeart Disease1 more

This study compares the effects of a standard smoking cessation treatment, including one-time brief counseling and provision of nicotine patch plus an 8-week moderate intensity exercise program versus the same standard smoking cessation treatment plus equivalent contact control among 60 healthy women. We hypothesize that participants in the smoking cessation plus moderate intensity exercise condition will be more likely to quit smoking than participants in the smoking cessation treament plus contact control condition.

Completed53 enrollment criteria

The Effect of Beer, Red Wine and Fruit Juice on Blood Vessel Function in Persons With Cardiovascular...

Coronary Heart Disease

To study the effect of red wine, beer and fruit juice on endothelial function in patients with coronary Heart disease.

Completed7 enrollment criteria

Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

HypertensionIschemic Heart Disease2 more

The KYOTO HEART Study is to assess the add-on effect of valsartan, an Angiotensin-Receptor Blocker, on top of the conventional treatment in high risk patients in Japan with hypertension in terms of the morbidity and mortality.

Completed10 enrollment criteria

Enhancing Support for Women at Risk for Heart Disease

Cardiovascular DiseasesHeart Diseases4 more

To test a practical, theory-based intervention to achieve long-term behavior change for postmenopausal women with Type 2 diabetes at high risk for developing coronary heart disease (CHD).

Completed1 enrollment criteria

Dose Response to Exercise and Cardiovascular Health

Cardiovascular DiseasesHeart Diseases

To determine the minimal dose of physical activity necessary to improve cardiovascular (CV) health by evaluating and aerobically training 500 healthy men and women, 30-65 years of age.

Completed1 enrollment criteria

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Heart DiseaseStroke2 more

The purpose of this study is to determine which of two treatments, Warfarin or aspirin, is better for preventing death and stroke in patients with poor heart function. We are now transitioning into the sub-analysis part of the WARCEF patient data. The study has recently completed data analysis for its Primary Aim. All randomized patients have completed their follow up. All study related procedure as per the protocol has been completed. We are now in the extension phase of the study to obtain more patient data to address further aims of the study. No new procedures are performed and data already in place at the sites will be collected (EKG and echocardiograms). The aims for this study extension are: To assess progression of cardiac dysfunction over time among heart failure patients To correlate prognosis with cardiac dysfunction

Completed19 enrollment criteria

Antiarrhythmic Effects of N-3 Fatty Acids

ArrhythmiaHeart Diseases3 more

To determine the antiarrhythmic effects of dietary N-3 fatty acids in patients with implanted defibrillators.

Completed1 enrollment criteria
1...152153154...353

Need Help? Contact our team!


We'll reach out to this number within 24 hrs